trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Carcinoma D002277 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Brain Neoplasms D001932 15 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Melanoma D008545 69 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Stroke D020521 32 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Nerve Degeneration D009410 53 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Nasal Polyps D009298 26 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Translocation, Genetic D014178 20 associated lipids
Cardiomegaly D006332 31 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Radiation Injuries D011832 14 associated lipids
Leishmaniasis D007896 19 associated lipids
Enteritis D004751 8 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Chondrosarcoma D002813 9 associated lipids
Osteomalacia D010018 5 associated lipids
Glioblastoma D005909 27 associated lipids
Keloid D007627 12 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Medulloblastoma D008527 22 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Cat Diseases D002371 12 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Retinoblastoma D012175 12 associated lipids
Genomic Instability D042822 7 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Mastocytoma D034801 3 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Progeria D011371 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Alao JP et al. Role of glycogen synthase kinase 3 beta (GSK3beta) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells. 2006 Mol. Cancer pmid:17018141
Arapshian A et al. Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer. 2004 Mol. Cancer pmid:15113415
Liu TY et al. EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis. 2010 Mol. Cancer pmid:20144199
Li Y et al. Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells. 2010 Mol. Cancer pmid:20946668
Kongruttanachok N et al. Replication independent DNA double-strand break retention may prevent genomic instability. 2010 Mol. Cancer pmid:20356374
Mühlethaler-Mottet A et al. Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells. 2008 Mol. Cancer pmid:18549473
Das PM et al. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. 2006 Mol. Cancer pmid:16848908
Alao JP et al. The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines. 2006 Mol. Cancer pmid:16503970
Alao JP et al. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. 2006 Mol. Cancer pmid:16504004
Chen WP et al. Alleviation of osteoarthritis by Trichostatin A, a histone deacetylase inhibitor, in experimental osteoarthritis. 2010 Mol. Biol. Rep. pmid:20237852
Marenzi S et al. Efficiency of expression of transfected genes depends on the cell cycle. 1999 Mol. Biol. Rep. pmid:10634509
Mittal MK et al. Mode of action of the retrogene product SNAI1P, a SNAIL homolog, in human breast cancer cells. 2010 Mol. Biol. Rep. pmid:19277896
Yin H et al. Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells. 2011 Mol. Biol. Rep. pmid:21181272
Royo H et al. Bsr, a nuclear-retained RNA with monoallelic expression. 2007 Mol. Biol. Cell pmid:17507654
Nishiyama A et al. Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: preservation of acetylated chromatin. 2006 Mol. Biol. Cell pmid:16339075
Agostinho M et al. Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis. 2004 Mol. Biol. Cell pmid:14978217
Cabrero JR et al. Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity. 2006 Mol. Biol. Cell pmid:16738306
Valenzuela-Fernández A et al. Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. 2005 Mol. Biol. Cell pmid:16148047
He Q et al. Characterization of an apical ceramide-enriched compartment regulating ciliogenesis. 2012 Mol. Biol. Cell pmid:22718902
Cimini D et al. Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects. 2003 Mol. Biol. Cell pmid:12972566
Li X and Bai XZ [NF-kappaB modulates activation of the BMP-2 gene by trichostatin A]. 2008 Nov-Dec Mol. Biol. (Mosk.) pmid:19140318
Kir'ianov GI et al. [Nucleosome positioning within neomycinphosphotransferase gene (NPTII) on yeast plasmid in repressed and active state]. 2008 Nov-Dec Mol. Biol. (Mosk.) pmid:19140324
Rahimian A et al. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism]. Mol. Biol. (Mosk.) pmid:29989579
Ramakrishnan G et al. Histone acetyltransferases and deacetylase in Entamoeba histolytica. 2004 Mol. Biochem. Parasitol. pmid:15555732
Isakov E et al. Trichostatin A regulates peroxiredoxin expression and virulence of the parasite Entamoeba histolytica. 2008 Mol. Biochem. Parasitol. pmid:18191469
Dubois F et al. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni. 2009 Mol. Biochem. Parasitol. pmid:19538992
Bricambert J et al. Impaired histone deacetylases 5 and 6 expression mimics the effects of obesity and hypoxia on adipocyte function. 2016 Mol Metab pmid:27900262
Habeck M Gelsolin: a new marker for breast cancer? 1999 Mol Med Today pmid:10562712
Peng L et al. Epigenetic inactivation of ADAMTS9 via promoter methylation in multiple myeloma. 2013 Mol Med Rep pmid:23358566
Meng J et al. Ku70 is essential for histone deacetylase inhibitor trichostatin A-induced apoptosis. 2015 Mol Med Rep pmid:25695595
Ma J et al. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines. 2015 Mol Med Rep pmid:25634603
Xiong J et al. USP22 transcriptional activity is negatively regulated by the histone deacetylase inhibitor trichostatin A. 2014 Mol Med Rep pmid:25323692
Han RF et al. Trichostatin A induces mesenchymal-like morphological change and gene expression but inhibits migration and colony formation in human cancer cells. 2014 Mol Med Rep pmid:25269990
Lu HG et al. TET1 partially mediates HDAC inhibitor-induced suppression of breast cancer invasion. 2014 Mol Med Rep pmid:25175940
Gao L et al. Histone deacetylase inhibitor trichostatin A and autophagy inhibitor chloroquine synergistically exert anti-tumor activity in H-ras transformed breast epithelial cells. 2018 Mol Med Rep pmid:29344672
Zhu XJ et al. Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer. 2014 Mol Med Rep pmid:24718752
Qu H et al. Trichostatin A increases the TIMP-1/MMP ratio to protect against osteoarthritis in an animal model of the disease. 2016 Mol Med Rep pmid:27431944
Meng CF et al. DNA demethylation is superior to histone acetylation for reactivating cancer-associated genes in ovarian cancer cells. 2011 Nov-Dec Mol Med Rep pmid:21850374
Du R et al. Trichostatin A potentiates genistein-induced apoptosis and reverses EMT in HEp2 cells. 2016 Mol Med Rep pmid:27121018
Zhang L et al. Effect of histone deacetylase inhibitors on cell apoptosis and expression of the tumor suppressor genes RUNX3 and ARHI in ovarian tumors. 2013 Mol Med Rep pmid:23504001
Tao LL et al. TSA increases C/EBP‑α expression by increasing its lysine acetylation in hepatic stellate cells. 2017 Mol Med Rep pmid:28849174
Zhang Q et al. Trichostatin A inhibits inflammation in phorbol myristate acetate‑induced macrophages by regulating the acetylation of histone and/or non‑histone proteins. 2016 Mol Med Rep pmid:26647731
Robers MB et al. Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technology. 2011 Mol Biosyst pmid:20931131
Jost JO et al. A miniaturized readout strategy for endogenous histone deacetylase activity. 2015 Mol Biosyst pmid:26009008
Hizaki K et al. Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis. 2011 Mod. Pathol. pmid:21317879
Higashiyama R et al. Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. 2010 Mod Rheumatol pmid:19784544
van West P et al. Internuclear gene silencing in Phytophthora infestans is established through chromatin remodelling. 2008 Microbiology (Reading, Engl.) pmid:18451057
Nakaya Y et al. Epigenetic regulation on the 5'-proximal CpG island of human porcine endogenous retrovirus subgroup A receptor 2/GPR172B. 2011 Microbes Infect. pmid:20951222
Liu C and Xu D Inhibition of histone deacetylases. 2004 Methods Mol. Biol. pmid:15273406
Garfinkel MD et al. Multigenerational selection and detection of altered histone acetylation and methylation patterns: toward a quantitative epigenetics in Drosophila. 2004 Methods Mol. Biol. pmid:15273410